Evidence map›Paper›PMID 29903768›Full record

ArticleClinical science (London, England : 1979)2018

Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats.

Alynne Carvalho-Galvão, Blessing Ogunlade, Jiaxi Xu, Cristiane R A Silva-Alves, Leônidas G Mendes-Júnior, Drielle D Guimarães, Josiane C Cruz, Thyago M Queiroz, Camille M Balarini, Valdir A Braga and 3 more

Abstract read
In one paragraph

Article in Clinical science (London, England : 1979), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. β-Arrestin-2 Regulates Sodium Taste Processing.Hypertension (Dallas, Tex. : 1979) · 2026
    Article
  2. Article
  3. Microglial activation and RAS signaling: a dual-edged sword in neuroinflammation.American journal of physiology. Regulatory, integrative and comparative physiology · 2026
    Review
  4. Review
  5. Insights Into the Role of Angiotensin-II ATHypertension (Dallas, Tex. : 1979) · 2024
    Review
  6. Article
  7. Comparative evaluation of biased agonists SarcosinePharmacology research & perspectives · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. β-Arrestin-Biased Agonist Targeting the Brain ATHypertension (Dallas, Tex. : 1979) · 2021
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Alynne Carvalho-GalvãoCentro de Biotecnologia, Universidade Federal da Paraíba, João Pessoa, Brazil.
Blessing OgunladeDepartment of Pharmacology, College of Medicine, Howard University, Washington, DC, U.S.A.
Jiaxi XuDepartment of Pharmacology and Experimental Therapeutics and Cardiovascular Center of Excellence, Louisiana State, University Health Sciences Center, New Orleans, LA, U.S.A.
Cristiane R A Silva-AlvesCentro de Biotecnologia, Universidade Federal da Paraíba, João Pessoa, Brazil.
Leônidas G Mendes-JúniorCentro de Biotecnologia, Universidade Federal da Paraíba, João Pessoa, Brazil.
Drielle D GuimarãesCentro de Biotecnologia, Universidade Federal da Paraíba, João Pessoa, Brazil.
Josiane C CruzCentro de Biotecnologia, Universidade Federal da Paraíba, João Pessoa, Brazil.
Thyago M QueirozFaculdade de Medicina, Universidade Federal do Ceará, Fortaleza, Brazil.
Camille M BalariniCentro de Biotecnologia, Universidade Federal da Paraíba, João Pessoa, Brazil.
Valdir A BragaCentro de Biotecnologia, Universidade Federal da Paraíba, João Pessoa, Brazil.
Catalin M FilipeanuDepartment of Pharmacology, College of Medicine, Howard University, Washington, DC, U.S.A.
Eric LazartiguesDepartment of Pharmacology and Experimental Therapeutics and Cardiovascular Center of Excellence, Louisiana State, University Health Sciences Center, New Orleans, LA, U.S.A. francasilva@cbiotec.ufpb.br elazar@lsuhsc.edu.
Maria do Socorro de França-SilvaCentro de Biotecnologia, Universidade Federal da Paraíba, João Pessoa, Brazil francasilva@cbiotec.ufpb.br elazar@lsuhsc.edu.
Universidade Federal da Paraíba · BRUniversidade Federal do Ceará · BR

Funding

Vascular and Cardiac Function Core - "Mentoring in Cardiovascular BiologyP30GM106392 · NIGMS · LSU HEALTH SCIENCES CENTER · PI NICHOLS, CHARLES D · 2014 to 2018
$5.5M
Mechanisms of ACE2 Regulation in Neurogenic HypertensionR01HL093178 · NHLBI · LSU HEALTH SCIENCES CENTER · PI LAZARTIGUES, ERIC D · 2008 to 2017
$3.4M
New strategies to restore ACE2 compensatory activity in neurogenic hypertensionI01BX004294 · VA · SOUTHEAST LOUISIANA VETERANS HEALTH CARE · PI LAZARTIGUES, ERIC D · 2018 to 2021
–
BLRD VA I01 BX004294NHLBI NIH HHS R01 HL093178NIGMS NIH HHS P30 GM106392
6 · The paper itself

Abstract

TRV027 is a biased agonist for the Angiotensin (Ang)-II type 1 receptor (AT

Indexed as

Angiotensin-Converting Enzyme 2Angiotensin IIAnimalsBaroreflexBlood PressureHEK293 CellsHumansHypertensionMesenteric ArteriesOligopeptidesPeptidyl-Dipeptidase AProtein BindingRats, Inbred SHRRats, Inbred WKYReceptor, Angiotensin, Type 1Vasoconstrictor AgentsACE2 protein, humanAce2 protein, ratAngiotensin-Converting Enzyme 2Angiotensin IIOligopeptidesPeptidyl-Dipeptidase AReceptor, Angiotensin, Type 1Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OHVasoconstrictor AgentsACE2ADAM17Biased agonisthypertensionrenin-angiotensin system

Identifiers

PMID29903768
PMCPMC6309978
OpenAlexW2808266397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.